Tenon Medical, Inc. 8-K

What Happened

• Tenon Medical (TNON) filed an 8-K (Items 1.01 and 5.02) disclosing its 2026 Executive Compensation Plan and an amendment to the Executive Chairman’s consulting agreement. The compensation changes were approved by the Compensation Committee and are effective March 1, 2026; the consulting agreement amendment is dated May 7, 2026.

Key Details

• Base salary increases: 5% raises effective March 1, 2026 — Steven M. Foster (CEO & President) to $420,000; Kevin Williamson (CFO) to $330,750; Richard Ginn (COO) to $304,500.
• Bonus opportunity changes: annual bonus for Foster set at 50% of base salary (milestone-based); Williamson and Ginn set at 35% of base salary (milestone-based).
• Additional milestone bonuses: up to $100,000 for Foster, $70,000 for Williamson, and $50,000 for Ginn, based on Board-determined milestones.
• Executive Chairman amendment: Richard Ferrari’s consulting agreement extended one year (May 7, 2026 – May 6, 2027). He will continue as Executive Chairman and be paid $45,000 per quarter ($180,000 annually). The amendment is filed as an exhibit.

Why It Matters

• These actions increase the company’s executive compensation commitments and align pay with milestone-based incentives. For investors, the changes may modestly raise near-term cash compensation expense (and create potential additional payout if milestones are met), while signaling the board’s priorities for management performance and retention. The Executive Chairman’s extension confirms continued leadership continuity under a consulting arrangement through May 2027.